These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34915854)

  • 1. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects.
    Peersen K; Munkhaugen J; Sverre E; Kristiansen O; Fagerland M; Vethe NT; Perk J; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2021 Dec; 21(1):596. PubMed ID: 34915854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-associated muscle symptoms in coronary patients: design of a randomized study.
    Munkhaugen J; Vethe NT; Fagerland MW; Dammen T; Perk J; Gjertsen E; Otterstad JE; Gullestad L; Bergan S; Husebye E
    Scand Cardiovasc J; 2019 Jun; 53(3):162-168. PubMed ID: 31030568
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial.
    Kristiansen O; Vethe NT; Peersen K; Wang Fagerland M; Sverre E; Prunés Jensen E; Lindberg M; Gjertsen E; Gullestad L; Perk J; Dammen T; Bergan S; Husebye E; Otterstad JE; Munkhaugen J
    Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):507-516. PubMed ID: 32609361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin-Associated Muscle Symptoms.
    Lauritzen T; Munkhaugen J; Peersen K; Kristiansen O; Sverre E; Nebauer SD; Villseth M; Andersen AM; Svarstad AC; Jensen EP; Bergan S; Husebye E; Vethe NT
    Clin Pharmacol Ther; 2023 Apr; 113(4):887-895. PubMed ID: 36622792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on SAMS: Statin-associated muscle symptoms.
    Stock JK
    Atherosclerosis; 2018 Feb; 269():260-261. PubMed ID: 29361270
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
    Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P;
    Lancet; 2017 Jun; 389(10088):2473-2481. PubMed ID: 28476288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
    Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
    J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care.
    Herrett E; Williamson E; Beaumont D; Prowse D; Youssouf N; Brack K; Armitage J; Goldacre B; MacDonald T; Staa TV; Roberts I; Shakur-Still H; Smeeth L
    BMJ Open; 2017 Dec; 7(12):e016604. PubMed ID: 29197834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
    Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
    Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
    Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial.
    Murphy WA; Lin N; Damask A; Schwartz GG; Steg PG; Szarek M; Banerjee P; Fazio S; Manvelian G; Pordy R; Shuldiner AR; Paulding C
    Circ Genom Precis Med; 2022 Jun; 15(3):e003503. PubMed ID: 35543701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features related to statin-associated muscle symptoms.
    Ochs-Balcom HM; Nguyen LM; Ma C; Isackson PJ; Luzum JA; Kitzmiller JP; Tarnopolsky M; Weisman M; Christopher-Stine L; Peltier W; Wortmann RL; Vladutiu GD
    Muscle Nerve; 2019 May; 59(5):537-543. PubMed ID: 30549046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
    Taylor BA; Thompson PD
    Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
    Nissen SE; Stroes E; Dent-Acosta RE; Rosenson RS; Lehman SJ; Sattar N; Preiss D; Bruckert E; Ceška R; Lepor N; Ballantyne CM; Gouni-Berthold I; Elliott M; Brennan DM; Wasserman SM; Somaratne R; Scott R; Stein EA;
    JAMA; 2016 Apr; 315(15):1580-90. PubMed ID: 27039291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
    Herrett E; Williamson E; Brack K; Beaumont D; Perkins A; Thayne A; Shakur-Still H; Roberts I; Prowse D; Goldacre B; van Staa T; MacDonald TM; Armitage J; Wimborne J; Melrose P; Singh J; Brooks L; Moore M; Hoffman M; Smeeth L;
    BMJ; 2021 Feb; 372():n135. PubMed ID: 33627334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Baseline Psychological Health on Muscle Pain During Atorvastatin Treatment.
    Zaleski AL; Taylor BA; Pescatello LS; Dornelas EA; White CM; Thompson PD
    J Cardiovasc Nurs; 2017; 32(6):544-550. PubMed ID: 27870723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No benefit of vitamin D supplementation on muscle function and health-related quality of life in primary cardiovascular prevention patients with statin-associated muscle symptoms: A randomized controlled trial.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
    J Clin Lipidol; 2024; 18(2):e269-e284. PubMed ID: 38177036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.